[ad_1]
Travere Therapeutics Travere Therapeutics TVTX $ 19.68 $0.69 3.39% 33% IBD Stock Analysis Stock with 25.29 consolidation buy point TVTX Actionable after March 25 high of 21.35 above 50-day Composite Rating 79/99 Industry Group Ranking 51/197 Emerging Pattern Consolidation Consolidation A sideways pattern that doesn’t fit traditional base definitions. Sometimes will have a handle. * Not real-time data. All data…
[ad_2]
Source link